Stock Scorecard
Stock Summary for Biogen Inc (BIIB) - $191.30 as of 5/8/2026 7:11:06 PM EST
Total Score
9 out of 30
Safety Score
42 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for BIIB
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for BIIB
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for BIIB
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for BIIB
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for BIIB (42 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 10 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for BIIB
Financial Details for BIIB
Company Overview |
|
|---|---|
| Ticker | BIIB |
| Company Name | Biogen Inc |
| Country | N/A |
| Description | Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - GENERAL |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 191.30 |
| Price 4 Years Ago | 276.92 |
| Last Day Price Updated | 5/8/2026 7:11:06 PM EST |
| Last Day Volume | 735,692 |
| Average Daily Volume | 1,239,158 |
| 52-Week High | 202.41 |
| 52-Week Low | 115.25 |
| Last Price to 52 Week Low | 65.99% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 21.06 |
| Sector PE | 81.50 |
| 5-Year Average PE | 20.86 |
| Free Cash Flow Ratio | 8.35 |
| Industry Free Cash Flow Ratio | 38.90 |
| Sector Free Cash Flow Ratio | 24.59 |
| Current Ratio Most Recent Quarter | 3.06 |
| Total Cash Per Share | 22.91 |
| Book Value Per Share Most Recent Quarter | 126.37 |
| Price to Book Ratio | 1.48 |
| Industry Price to Book Ratio | 7.78 |
| Sector Price to Book Ratio | 9.97 |
| Price to Sales Ratio Twelve Trailing Months | 2.81 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.79 |
| Sector Price to Sales Ratio Twelve Trailing Months | 4.70 |
| Analyst Buy Ratings | 17 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 147,637,000 |
| Market Capitalization | 28,242,958,100 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 3.71% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 31.10% |
| Annual Earnings Growth | -20.76% |
| Reported EPS 12 Trailing Months | 9.30 |
| Reported EPS Past Year | 3.57 |
| Reported EPS Prior Year | 15.29 |
| Net Income Twelve Trailing Months | 1,372,389,000 |
| Net Income Past Year | 1,293,389,000 |
| Net Income Prior Year | 1,632,200,000 |
| Quarterly Revenue Growth YOY | 1.90% |
| 5-Year Revenue Growth | -6.11% |
| Operating Margin Twelve Trailing Months | 22.90% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 3,382,700,000 |
| Total Cash Past Year | 3,008,500,000 |
| Total Cash Prior Year | 2,375,000,000 |
| Net Cash Position Most Recent Quarter | -2,905,800,000 |
| Net Cash Position Past Year | -3,278,300,000 |
| Long Term Debt Past Year | 6,286,800,000 |
| Long Term Debt Prior Year | 4,547,200,000 |
| Total Debt Most Recent Quarter | 6,288,500,000 |
| Equity to Debt Ratio Past Year | 0.74 |
| Equity to Debt Ratio Most Recent Quarter | 0.75 |
| Total Stockholder Equity Past Year | 18,256,800,000 |
| Total Stockholder Equity Prior Year | 16,716,000,000 |
| Total Stockholder Equity Most Recent Quarter | 18,651,700,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 2,432,900,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 16.48 |
| Free Cash Flow Past Year | 2,050,800,000 |
| Free Cash Flow Prior Year | 2,515,700,000 |
Options |
|
| Put/Call Ratio | 0.08 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.50 |
| MACD Signal | -0.65 |
| 20-Day Bollinger Lower Band | 164.83 |
| 20-Day Bollinger Middle Band | 181.96 |
| 20-Day Bollinger Upper Band | 199.09 |
| Beta | 0.20 |
| RSI | 50.82 |
| 50-Day SMA | 158.16 |
| 150-Day SMA | 191.55 |
| 200-Day SMA | 210.20 |
System |
|
| Modified | 5/8/2026 6:38:14 PM EST |